Clinical Trials Logo

Clinical Trial Summary

Sleep bruxism is a masticatory muscle activity characterized as rhythmic (phasic) or non‐rhythmic (tonic). The literature reports the prevalence rates, diverse etiologies and different types of treatment. In children and adolescents, etiological factors, such as breathing pattern and sleep quality, have recently been addressed in studies investigating sleep bruxism. While studies have also reported psychological factors as a causal factor, this aspect requires further research. There are also divergences in opinion regarding the form of treatment. New therapies for adults, such as botulinum toxin, have been investigated, but such techniques are not applicable for individuals in the growth and development phase. Thus, photobiomodulation therapy has piqued the interest of researchers, as this noninvasive method has demonstrated positive results in problems related to muscle tissues. This document describes the protocol for a proposed study to evaluate morphological and psychosocial aspects in children and adolescents with awake bruxism and their responses to photobiomodulation therapy with infrared LED.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03710174
Study type Interventional
Source University of Nove de Julho
Contact
Status Recruiting
Phase Phase 2
Start date August 1, 2017
Completion date April 10, 2019

See also
  Status Clinical Trial Phase
Completed NCT03833505 - Enterobius Vermicularis and Bruxism in Children
Completed NCT03810248 - Association Between Obstructive Sleep Apnea and Bruxism
Completed NCT04842136 - Factors Affecting Patients With Myofascial Temporomandibular Disorders
Withdrawn NCT03749928 - OstiSense Biosensor in Bruxism Reduction - A Clinical Study N/A